D. E. Shaw & Co., Inc. Dice Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$25.86 - $46.71 $6.02 Million - $10.9 Million	-232,788 Reduced 41.85%	323,453 $15 Million
Q1 2023 May 15, 2023	SELL	$26.05 - $32.31 $3.3 Million - $4.09 Million	-126,693 Reduced 18.55%	556,241 $15.9 Million
Q4 2022 Feb 14, 2023	BUY	$19.77 - $42.23 $13.5 Million - $28.8 Million	682,934 New	682,934 $21.3 Million
Q2 2022 Aug 15, 2022	SELL	$13.19 - $22.1 $141,370 - $236,867	-10,718 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$14.54 - $25.02 $776,843 - $1.34 Million	-53,428 Reduced 83.29%	10,718 $205,000
Q4 2021 Feb 14, 2022	BUY	$22.41 - $37.54 $1.44 Million - $2.41 Million	64,146 New	64,146 $1.62 Million

17.7K

13K

Ticker DICE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,430,000
Description
DICE Therapeutics, Inc., a biopharmaceutical company, builds various oral therapeutic candidates to treat chronic diseases in immunology and other therapeutic areas. Its platform DELSCAPE, is designed to discover selective oral small molecules to modulate protein-protein interactions (PPIs) as effectively as systemic biologics. The company's lea...

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.